ETON Eton Pharmaceuticals, Inc.
$51.80▲ +1.25%
Healthcare
Other
Volume 324.1K
Avg Volume (10D) 393.3K
Key Metrics & Fundamentals
Market Cap
$1.48B
P/E Ratio
129.5
Div Yield
0.00%
52W Range
14.27 - 66.37
% vs 50 MA
-8.02%
% vs 200 MA
46.60%
RSI-14
46.3
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.20
Free Cash Flow
$7.26M
Gross Rev
$37.59M
Gross Profit
$25.41M
EBITDA
$14.18M
COGS
$12.18M
Operating Exp
$12.62M
Operating Income
$12.79M
EBIT
$12.79M
Pretax Income
$11.72M
Net Income
$11.58M
EPS (Diluted)
0.35
Price & Volume History
Loading chart…
Recent News
Eton Pharmaceuticals (ETON) Stock Still Looks Rich Despite Its New Seizure Drug License
Simply Wall St. · Oct 22, 2026 3:13 PM ET
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday
MT Newswires · Oct 14, 2026 9:23 AM ET
Eton Pharmaceuticals Licenses US Rights to Aquestive's Epilepsy Drug
MT Newswires · Oct 14, 2026 7:15 AM ET
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
GlobeNewswire · Oct 14, 2026 6:50 AM ET
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know
Zacks · Oct 13, 2026 9:47 AM ET
Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases
Zacks · Oct 13, 2026 9:41 AM ET
ETON Stock Surges 108% in Six Months: Here's What You Need to Know
Zacks · Oct 7, 2026 11:08 AM ET
Eton Pharmaceuticals Launches Impavido Capsules to Treat Leishmaniasis
MT Newswires · Sep 28, 2026 7:37 AM ET
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules
GlobeNewswire · Sep 28, 2026 6:50 AM ET
Eton Pharmaceuticals Insider Sold Shares Worth $2,953,572, According to a Recent SEC Filing
MT Newswires · Aug 28, 2026 4:56 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ETON's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.